Suzanne M. Noble

Suzanne M. Noble

Auto-generated profile, based on publicly available information

Suzanne M. Noble

Department of Microbiology & Immunology, University of California, San Francisco, San Francisco, CA, USA

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2010 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SNSuzanne M Noble
Suzanne M Noble
SFSarah French
Sarah French
LKLisa A Kohn
Lisa A Kohn
VCVictoria Chen
Victoria Chen
AJAlexander D Johnson
Alexander D Johnson
Suzanne Noble and colleagues present a library of ∼3,000 homozygous gene deletion strains of Candida albicans. The authors screened for infectivity in a mouse model and for yeast-to-hypha morphological switching. They identified 115 infectivity-attenuated mutants, half of which demonstrated normal morphological switching. Candida albicans is the most common cause of serious fungal disease in humans. Creation of isogenic null mutants of this diploid organism, which requires sequential gene targeting, allows dissection of virulence mechanisms. Published analyses of such mutants show a near-perfect correlation between C. albicans pathogenicity and the ability to undergo a yeast-to-hypha morphological switch in vitro. However, most studies have used mutants constructed with a marker that is itself a virulence determinant and therefore complicates their interpretation. Using alternative markers, we created ∼3,000 homozygous deletion strains affecting 674 genes, or roughly 11% of the C. albicans genome. Screening for infectivity in a mouse model and for morphological switching and cell proliferation in vitro, we identified 115 infectivity-attenuated mutants, of which nearly half demonstrated normal morphological switching and proliferation. Analysis of such mutants revealed that virulence requires the glycolipid glucosylceramide. To our knowledge, this is the first C. albicans small molecule that has been found to be required specifically for virulence.

21 November 2016 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
SNSuzanne M. Noble
Suzanne M. Noble
BGBrittany A. Gianetti
Brittany A. Gianetti
JWJessica N. Witchley
Jessica N. Witchley

28 July 2013 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KPKalyan Pande
Kalyan Pande
CCChangbin Chen
Changbin Chen
SNSuzanne M Noble
Suzanne M Noble
Suzanne Noble and colleagues show that the passage of Candida albicans through the mammalian gut induces expression of the Wor1 transcription factor, triggering a developmental switch that promotes commensal fitness. Among ∼5,000,000 fungal species1, C. albicans is exceptional in its lifelong association with humans, either within the gastrointestinal microbiome or as an invasive pathogen2. Opportunistic infections are generally ascribed to defective host immunity3 but may require specific microbial programs. Here we report that exposure of C. albicans to the mammalian gut triggers a developmental switch, driven by the Wor1 transcription factor, to a commensal cell type. Wor1 expression was previously observed only in rare genetic backgrounds4,5,6, where it controls a white-opaque switch in mating4,5,6,7. We show that passage of wild-type cells through the mouse gastrointestinal tract triggers WOR1 expression and a novel phenotypic switch. The resulting GUT (gastrointestinally induced transition) cells differ morphologically and functionally from previously defined cell types, including opaque cells, and express a transcriptome that is optimized for the digestive tract. The white-GUT switch illuminates how a microorganism can use distinct genetic programs to transition between commensalism and invasive pathogenesis.

1 March 2019 in Cell Host & Microbe
Verified
Journal Article
Closed access
JWJessica N. Witchley
Jessica N. Witchley
PPPallavi Penumetcha
Pallavi Penumetcha
NANina V. Abon
Nina V. Abon
CWCarol A. Woolford
Carol A. Woolford
AMAaron P. Mitchell
Aaron P. Mitchell
SNSuzanne M. Noble
Suzanne M. Noble

1 December 2013 in Current Opinion in Microbiology
Verified
Journal Article
Closed access
SNSuzanne M Noble
Suzanne M Noble

1 December 2007 in Annual Review of Genetics
Verified
Journal Article
Closed access
SNSuzanne M. Noble
Suzanne M. Noble
AJAlexander D. Johnson
Alexander D. Johnson
Candida albicans is a species of fungus that typically resides in the gastrointestinal tracts of humans and other warm-blooded animals. It is also the most common human fungal pathogen, causing a variety of skin and soft tissue infections in healthy people and more virulent invasive and disseminated diseases in patients with compromised immune systems. How this microorganism manages to persist in healthy hosts but also to cause a spectrum of disease states in the immunocompromised host are questions of significant biological interest as well as major clinical and economic importance. In this review, we describe recent developments in population genetics, the mating process, and gene disruption technology that are providing much needed experimental insights into the biology of C. albicans.